Akemi Kuromiya
Sumitomo Dainippon Pharma (Japan)(JP)
Publications by Year
Research Areas
Aldose Reductase and Taurine, Biochemical effects in animals, Prenatal Substance Exposure Effects, Immune Response and Inflammation, Cannabis and Cannabinoid Research
Most-Cited Works
- → Novel, Highly Potent Aldose Reductase Inhibitors: (R)-(−)-2-(4-Bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine- 4-spiro-3‘-pyrrolidine-1,2‘,3,5‘-tetrone (AS-3201) and Its Congeners(1998)123 cited
- → Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbitol Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetic Rats(2008)50 cited
- → Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats(2008)42 cited
- → Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury(2009)17 cited
- → Improvement of Motor Nerve Conduction Velocity in Diabetic Rats Requires Normalization of the Polyol Pathway Metabolites Flux(2009)11 cited
- → ChemInform Abstract: Novel, Highly Potent Aldose Reductase Inhibitors: (R)‐(‐)‐2‐(4‐Bromo‐2‐fluorobenzyl)‐1,2,3,4‐tetrahydropyrrolo [1,2‐a]pyrazine‐4‐spiro‐3′‐pyrrolidine‐1,2′,3,5′‐tetrone (AS‐3201) and Its Congeners.(1999)1 cited